WEIGHT LOSS PROGRAM

THIS PROGRAM INCLUDES:

SEMAGLUTIDE & TIRZEPATIDE FOR WEIGHT LOSS

Semaglutide and Tirzepatide are new, FDA-approved treatments designed for weight loss in overweight and obese patients. As GLP-1 receptor agonists, they help manage hunger and regulate blood sugar. Research indicates that those taking these weekly injections could shed up to 15% of their body weight in as little as 6 months.

SELECTION CRITERIA

  • Overweight (BMI over 25) with conditions like high blood pressure, high cholesterol, or PCOS.
  • Obesity (BMI over 30).
  • Non-Diabetic.
  • No personal or family history of multiple endocrine neoplasia syndrome type 2 or thyroid cancer.

SIDE EFFECTS

  • Gastrointestinal Issues (Nausea, Vomiting, Diarrhea, Abdominal Pain or Fullness, Constipation)
  • Allergic Reactions
  • Retinal Damage (Especially For Those With Heart Disease)
  • Hypoglycemia

AFTER CARE

  • Maintain healthy eating, stay active, and hydrate well.
  • Notify your provider at the injection site if there’s any noticeable redness or swelling.
  • Always discuss medication changes with your provider before making adjustments.

NOTE

A full evaluation is required before starting weight loss management, but it’s important to understand that outcomes can differ for each person.

Let’s get started on your journey, tap below to book your evaluation and see where it takes you!

Note: Notify your provider if there’s any noticeable redness or swelling at the injection site